Boston Scientific Corporation (NYSE: BSX) announces the U.S. and international launch of the WallFlex® Biliary Transhepatic Stent System. This third-generation stent platform is now available with a percutaneous delivery system designed for use by interventional radiologists in the palliative treatment of biliary strictures produced by malignant tumors. The WallFlex Biliary Transhepatic Fully Covered Stent System is also available for the treatment of benign biliary strictures in CE marked countries.
On 21 November, Covidien announced a definitive agreement to acquire Barrx Medical, leader in the treatment of Barrett’s esophagus syndrome using bipolar radiofrequency (RF) ablation devices.
A minimally invasive embolization procedure, in which polyvinyl alcohol (PVA) particles are injected into the blood vessels to the nose, may be an effective therapy to decrease or stop nosebleed recurrence rates, according to a study being presented at the 24th annual International Symposium on Endovascular Therapy (ISET), Miami, USA.
At CIRSE 2011, in Munich, Germany, two experts told delegates what the evidence on renal denervation says so far, what studies ought to examine in the future, and what the potential downsides of the catheter-based treatment could be.
On 23 February 2012, Vessix Vascular announced initial patient treatments in the international multicentre REDUCE-HTN renal denervation clinical study for uncontrolled hypertension. REDUCE-HTN is a non-randomised, prospective, single cohort, 64-patient clinical study designed to validate the clinical performance of the Vessix V2 Renal Denervation System for medication-resistant hypertensive patients. Renal denervation is a new percutaneous catheter-based procedure that disrupts renal sympathetic nerves whose hyperactivity leads to abnormally high blood pressure.
Delcath Systems announced on 27 February that the first patients in Germany have been treated with the Delcath Hepatic Chemosat Delivery System at the Johann Wolfgang Goethe University Hospital, a premier European cancer treatment and research center located in Frankfurt. The cases were treated as part of the initial launch and training agreement the company announced with the hospital in December 2011.
Avinger has announced the enrolment of the first US patient in the multicentre, non-randomised CONNECT II global clinical trial designed to evaluate the safety and efficacy of the company’s Ocelot, the first-ever chronic total occlusion crossing catheter to use real-time intravascular optical coherence tomography (OCT) imaging technology.
With laser-guided motion technology on a motorised mobile gantry for predictable and precise trajectories, Wide Bore 3D for ease in 3D acquisitions, and more than 20 advanced applications available, the Discovery IGS 730 is positioned for a new era of interventional procedures. The significance of this innovation to interventional imaging has been compared to that of the invention of flat panel technology.
Hansen Medical announced it will showcase its Magellan robotic system at the Leipzig Interventional Course (LINC), from 25–28 January 2012 at the Trade Fair Leipzig, Hall 4, in Leipzig, Germany.
Researchers have published the largest single patient population study to date on a method for following patients with retrievable inferior vena cava (IVC) filters in the Journal of Vascular and Interventional Radiology. This study, which is important for individuals with IVC filters and their doctors, supports existing guidelines developed by the Society of Interventional Radiology.
ReCor Medical has announced that its Paradise percutaneous renal denervation system ultrasound platform for achieving renal denervation has received CE mark. Paradise is designed to treat patients with ‘resistant’ hypertension.
A study presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2011, Munich, Germany, shows that percutaneous cryoablation may be an alternative therapy in patients with renal tumours who are poor candidates for surgery.
The Cleveland Clinic Medical Innovations Summit for cardiovascular technologies has identified the Top 10 Medical Innovations for 2012, ie, the upand- coming technologies that will have the biggest impact on healthcare in 2012. Topping the list is catheter-based renal denervation to control resistant hypertension.
The Society of Interventional Radiology (SIR) released a position statement on the maintenance of credentials for image-guided interventions that lays out guidelines for the continuation of non-coronary percutaneous artery interventional procedures privileges in the hospital setting—saying that outcomes are a more important measure of quality than procedure volume alone.
Robert J Kennedy, interventional radiologist, Holmes Regional Medical Center, Melbourne, Florida, USA, presented data on thrombus resolution and haemodynamic recovery using ultrasound accelerated thrombolysis in acute pulmonary embolism at the International Symposium on Endovascular Therapy (ISET) in Miami, Florida.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos